日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025

加拿大乳腺癌诊疗指南：2025年HR+/HER2-转移性乳腺癌患者系统治疗国家共识建议

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33020106
Jerzak, Katarzyna J; Kumar, Aalok; Boileau, Jean-François; Bouganim, Nathaniel; Brezden-Masley, Christine; Cao, Jeffrey Q; Cescon, David W; Chia, Stephen; Edwards, Scott; Joy, Anil Abraham; Laing, Kara; LeVasseur, Nathalie; Lupichuk, Sasha; Sehdev, Sandeep; Simmons, Christine; Webster, Marc; Gelmon, Karen A; Manna, Mita; On Behalf Of Patient Advocacy Breast Cancer Canada
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025

加拿大乳腺癌诊疗指南：2025年HR+/HER2-早期乳腺癌患者系统治疗国家共识建议

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33020112
Sehdev, Sandeep; Joy, Anil Abraham; Boileau, Jean-François; Bouganim, Nathaniel; Brezden-Masley, Christine; Cao, Jeffrey Q; Cescon, David W; Chia, Stephen; Edwards, Scott; Gelmon, Karen A; Jerzak, Katarzyna J; Kumar, Aalok; Laing, Kara; LeVasseur, Nathalie; Simmons, Christine; Webster, Marc; Manna, Mita; On Behalf Of Patient Advocacy Breast Cancer Canada
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial

二十二碳六烯酸 (DHA) 补充剂可减轻接受新辅助治疗的乳腺癌患者外周血免疫细胞的浓度、表型和反应的变化。这是 DHA-WIN 试验的次要发现。

期刊:Breast Cancer Research
影响因子:6.1
doi:10.1186/s13058-025-02048-z
Jaqueline Munhoz ，Marnie Newell ，Susan Goruk ，Sunita Ghosh ，Dhruvesh Patel ，Anil Abraham Joy ，Gilbert Bigras ，Vera Mazurak ，Kerry S Courneya ，Denise G Hemmings ，Catherine J Field
细胞生物学
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double-blind, randomized controlled DHA-WIN trial

二十二碳六烯酸补充剂在乳腺癌新辅助治疗中的安全性和有效性：来自 II 期双盲随机对照 DHA-WIN 试验的结果

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.35517
Munhoz, Jaqueline; Newell, Marnie; Bigras, Gilbert; Goruk, Susan; Joy, Anil Abraham; Ghosh, Sunita; Courneya, Kerry S; Mazurak, Vera; Douglas, Claire M; Zhu, Xiaofu; Zorniak, Bohdarianna; Mackey, John; Junco, Judith Meza; Hiller, Julie Price; King, Karen; Basi, Sanraj K; Field, Catherine J
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Role of Qualified Exercise Professionals in Medical Clearance for Exercise: Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study

合格运动专业人员在运动医学评估中的作用：阿尔伯塔省癌症运动混合有效性实施研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17172873
McNeely, Margaret L; Williamson, Tanya; Shallwani, Shirin M; Ternes, Leslie; Sellar, Christopher; Joy, Anil Abraham; Lau, Harold; Easaw, Jacob; Brown, Adam; Courneya, Kerry S; Culos-Reed, S Nicole
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Baseline Characteristics of Participants in the Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study: A Wake-Up Call for Action

阿尔伯塔省癌症运动混合有效性实施研究参与者的基线特征：行动的警钟

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17050772
McNeely, Margaret L; Shallwani, Shirin M; Williamson, Tanya; Sellar, Christopher; Gobeil, Elaine; Joy, Anil Abraham; Lau, Harold; Easaw, Jacob; Sexsmith, John; Courneya, Kerry S; Culos-Reed, S Nicole
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Baseline Characteristics of Individuals with Metastatic Cancer Enrolled in the Alberta Cancer Exercise Study and 12-Week Findings for Symptom-Related and Physical Fitness Measures

阿尔伯塔癌症运动研究中转移性癌症患者的基线特征及12周症状相关和身体素质指标结果

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32100560
Shallwani, Shirin M; Culos-Reed, S Nicole; Courneya, Kerry S; Williamson, Tanya; Sellar, Christopher; Lau, Harold; Joy, Anil Abraham; Easaw, Jacob C; Audoin, Michelle; Pituskin, Edith; McNeely, Margaret L
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Continuous versus Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer

CCTG MA.38试验中晚期乳腺癌患者持续帕博西尼治疗与标准帕博西尼治疗及实体组织和液体活检的分子谱分析

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-25-0346
Joy, Anil Abraham; Cheng, Nicholas; Gelmon, Karen A; Mates, Mihaela; Desbiens, Christine; Clemons, Mark; Taylor, Sara; Lemieux, Julie; DeLuca, Angela; Gasparini, Louis; Lungu, Ilinca; Soave, David; Fortuna, Alex; Pugh, Trevor; Liu, Shuo Shuo; Bartlett, John M S; Awadalla, Philip; Spears, Melanie; Chen, Bingshu E; Bayani, Jane; Parulekar, Wendy R
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting

加拿大乳腺癌诊疗指南：HER2阳性乳腺癌早期和转移期患者系统治疗的国家共识建议

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol31110484
Manna, Mita; Gelmon, Karen A; Boileau, Jean-François; Brezden-Masley, Christine; Cao, Jeffrey Q; Jerzak, Katarzyna J; Prakash, Ipshita; Sehdev, Sandeep; Simmons, Christine; Bouganim, Nathaniel; Brackstone, Muriel; Cescon, David W; Chia, Stephen; Dayes, Ian S; Edwards, Scott; Hilton, John; Joy, Anil Abraham; Laing, Kara; Webster, Marc; Henning, Jan-Willem
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer

加拿大乳腺癌诊疗指南：新诊断乳腺癌患者临床分期的国家共识建议

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol31110533
Cao, Jeffrey Q; Surgeoner, Brae; Manna, Mita; Boileau, Jean-François; Gelmon, Karen A; Brackstone, Muriel; Brezden-Masley, Christine; Jerzak, Katarzyna J; Prakash, Ipshita; Sehdev, Sandeep; Wong, Stephanie M; Bouganim, Nathaniel; Cescon, David W; Chia, Stephen; Dayes, Ian S; Joy, Anil Abraham; Henning, Jan-Willem
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏